nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—ovarian cancer	0.504	1	CbGaD
Indacaterol—ABCB1—Topotecan—ovarian cancer	0.0772	0.221	CbGbCtD
Indacaterol—ABCB1—Vinorelbine—ovarian cancer	0.0544	0.156	CbGbCtD
Indacaterol—CYP3A4—Topotecan—ovarian cancer	0.0463	0.133	CbGbCtD
Indacaterol—ABCB1—Paclitaxel—ovarian cancer	0.0382	0.11	CbGbCtD
Indacaterol—CYP3A4—Vinorelbine—ovarian cancer	0.0326	0.0935	CbGbCtD
Indacaterol—ABCB1—Docetaxel—ovarian cancer	0.0276	0.0792	CbGbCtD
Indacaterol—CYP3A4—Paclitaxel—ovarian cancer	0.0229	0.0657	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—ovarian cancer	0.0206	0.0591	CbGbCtD
Indacaterol—CYP3A4—Docetaxel—ovarian cancer	0.0166	0.0475	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—ovarian cancer	0.0123	0.0354	CbGbCtD
Indacaterol—Bronchospasm—Melphalan—ovarian cancer	0.00127	0.00859	CcSEcCtD
Indacaterol—Rhinorrhoea—Docetaxel—ovarian cancer	0.00126	0.00856	CcSEcCtD
Indacaterol—Musculoskeletal pain—Paclitaxel—ovarian cancer	0.00122	0.00828	CcSEcCtD
Indacaterol—Pneumonia—Topotecan—ovarian cancer	0.00118	0.008	CcSEcCtD
Indacaterol—Infestation NOS—Topotecan—ovarian cancer	0.00117	0.00795	CcSEcCtD
Indacaterol—Infestation—Topotecan—ovarian cancer	0.00117	0.00795	CcSEcCtD
Indacaterol—Chest discomfort—Docetaxel—ovarian cancer	0.00116	0.00784	CcSEcCtD
Indacaterol—Oropharyngeal pain—Docetaxel—ovarian cancer	0.00112	0.00763	CcSEcCtD
Indacaterol—Bronchospasm—Vinorelbine—ovarian cancer	0.00111	0.00751	CcSEcCtD
Indacaterol—Angina pectoris—Vinorelbine—ovarian cancer	0.0011	0.00743	CcSEcCtD
Indacaterol—Connective tissue disorder—Melphalan—ovarian cancer	0.00101	0.00687	CcSEcCtD
Indacaterol—Pneumonia—Vinorelbine—ovarian cancer	0.00101	0.00684	CcSEcCtD
Indacaterol—Infestation NOS—Vinorelbine—ovarian cancer	0.001	0.0068	CcSEcCtD
Indacaterol—Infestation—Vinorelbine—ovarian cancer	0.001	0.0068	CcSEcCtD
Indacaterol—Tremor—Chlorambucil—ovarian cancer	0.000964	0.00654	CcSEcCtD
Indacaterol—Anaemia—Chlorambucil—ovarian cancer	0.000951	0.00645	CcSEcCtD
Indacaterol—Immune system disorder—Topotecan—ovarian cancer	0.000951	0.00645	CcSEcCtD
Indacaterol—Mediastinal disorder—Topotecan—ovarian cancer	0.000949	0.00644	CcSEcCtD
Indacaterol—Immune system disorder—Melphalan—ovarian cancer	0.000931	0.00632	CcSEcCtD
Indacaterol—Mediastinal disorder—Melphalan—ovarian cancer	0.000929	0.0063	CcSEcCtD
Indacaterol—Atrial fibrillation—Paclitaxel—ovarian cancer	0.000924	0.00627	CcSEcCtD
Indacaterol—Malnutrition—Topotecan—ovarian cancer	0.000916	0.00622	CcSEcCtD
Indacaterol—Connective tissue disorder—Vinorelbine—ovarian cancer	0.000885	0.006	CcSEcCtD
Indacaterol—Muscle spasms—Topotecan—ovarian cancer	0.000881	0.00598	CcSEcCtD
Indacaterol—Anaemia—Topotecan—ovarian cancer	0.000847	0.00575	CcSEcCtD
Indacaterol—Cardiac disorder—Vinorelbine—ovarian cancer	0.000836	0.00567	CcSEcCtD
Indacaterol—Infection—Chlorambucil—ovarian cancer	0.000835	0.00566	CcSEcCtD
Indacaterol—Anaemia—Melphalan—ovarian cancer	0.000829	0.00563	CcSEcCtD
Indacaterol—Immune system disorder—Vinorelbine—ovarian cancer	0.000813	0.00552	CcSEcCtD
Indacaterol—Mediastinal disorder—Vinorelbine—ovarian cancer	0.000812	0.0055	CcSEcCtD
Indacaterol—Cough—Topotecan—ovarian cancer	0.0008	0.00542	CcSEcCtD
Indacaterol—Hypokalaemia—Paclitaxel—ovarian cancer	0.000797	0.0054	CcSEcCtD
Indacaterol—Malnutrition—Vinorelbine—ovarian cancer	0.000784	0.00532	CcSEcCtD
Indacaterol—Atrial fibrillation—Docetaxel—ovarian cancer	0.000783	0.00531	CcSEcCtD
Indacaterol—Cough—Melphalan—ovarian cancer	0.000783	0.00531	CcSEcCtD
Indacaterol—Nasopharyngitis—Paclitaxel—ovarian cancer	0.000783	0.00531	CcSEcCtD
Indacaterol—Chest pain—Topotecan—ovarian cancer	0.00078	0.00529	CcSEcCtD
Indacaterol—Myalgia—Topotecan—ovarian cancer	0.00078	0.00529	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000775	0.00526	CcSEcCtD
Indacaterol—Myalgia—Melphalan—ovarian cancer	0.000764	0.00518	CcSEcCtD
Indacaterol—Chest pain—Melphalan—ovarian cancer	0.000764	0.00518	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000759	0.00515	CcSEcCtD
Indacaterol—Infection—Topotecan—ovarian cancer	0.000743	0.00504	CcSEcCtD
Indacaterol—Nervous system disorder—Topotecan—ovarian cancer	0.000733	0.00497	CcSEcCtD
Indacaterol—Infection—Melphalan—ovarian cancer	0.000728	0.00493	CcSEcCtD
Indacaterol—Skin disorder—Topotecan—ovarian cancer	0.000727	0.00493	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000725	0.00492	CcSEcCtD
Indacaterol—Anaemia—Vinorelbine—ovarian cancer	0.000725	0.00491	CcSEcCtD
Indacaterol—Tachycardia—Melphalan—ovarian cancer	0.000715	0.00485	CcSEcCtD
Indacaterol—Skin disorder—Melphalan—ovarian cancer	0.000711	0.00482	CcSEcCtD
Indacaterol—Vertigo—Vinorelbine—ovarian cancer	0.000704	0.00478	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.000703	0.00477	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—ovarian cancer	0.000698	0.00473	CcSEcCtD
Indacaterol—Palpitations—Vinorelbine—ovarian cancer	0.000693	0.0047	CcSEcCtD
Indacaterol—Cough—Vinorelbine—ovarian cancer	0.000684	0.00464	CcSEcCtD
Indacaterol—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000683	0.00463	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000681	0.00462	CcSEcCtD
Indacaterol—Pneumonia—Paclitaxel—ovarian cancer	0.000679	0.0046	CcSEcCtD
Indacaterol—Infestation NOS—Paclitaxel—ovarian cancer	0.000675	0.00458	CcSEcCtD
Indacaterol—Infestation—Paclitaxel—ovarian cancer	0.000675	0.00458	CcSEcCtD
Indacaterol—Paraesthesia—Topotecan—ovarian cancer	0.000672	0.00456	CcSEcCtD
Indacaterol—Chest pain—Vinorelbine—ovarian cancer	0.000667	0.00453	CcSEcCtD
Indacaterol—Myalgia—Vinorelbine—ovarian cancer	0.000667	0.00453	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000667	0.00453	CcSEcCtD
Indacaterol—Dyspnoea—Topotecan—ovarian cancer	0.000667	0.00452	CcSEcCtD
Indacaterol—Nasopharyngitis—Docetaxel—ovarian cancer	0.000664	0.0045	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000663	0.0045	CcSEcCtD
Indacaterol—Paraesthesia—Melphalan—ovarian cancer	0.000658	0.00446	CcSEcCtD
Indacaterol—Dyspnoea—Melphalan—ovarian cancer	0.000653	0.00443	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—ovarian cancer	0.000646	0.00438	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000646	0.00438	CcSEcCtD
Indacaterol—Infection—Vinorelbine—ovarian cancer	0.000636	0.00431	CcSEcCtD
Indacaterol—Sinusitis—Paclitaxel—ovarian cancer	0.000633	0.00429	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000632	0.00429	CcSEcCtD
Indacaterol—Bronchospasm—Docetaxel—ovarian cancer	0.000631	0.00428	CcSEcCtD
Indacaterol—Nervous system disorder—Vinorelbine—ovarian cancer	0.000627	0.00426	CcSEcCtD
Indacaterol—Angina pectoris—Docetaxel—ovarian cancer	0.000625	0.00424	CcSEcCtD
Indacaterol—Tachycardia—Vinorelbine—ovarian cancer	0.000624	0.00424	CcSEcCtD
Indacaterol—Skin disorder—Vinorelbine—ovarian cancer	0.000621	0.00422	CcSEcCtD
Indacaterol—Hypersensitivity—Chlorambucil—ovarian cancer	0.000619	0.0042	CcSEcCtD
Indacaterol—Oedema peripheral—Paclitaxel—ovarian cancer	0.000597	0.00405	CcSEcCtD
Indacaterol—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000595	0.00404	CcSEcCtD
Indacaterol—Pruritus—Chlorambucil—ovarian cancer	0.000594	0.00403	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000583	0.00395	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—ovarian cancer	0.000576	0.0039	CcSEcCtD
Indacaterol—Pneumonia—Docetaxel—ovarian cancer	0.000575	0.0039	CcSEcCtD
Indacaterol—Paraesthesia—Vinorelbine—ovarian cancer	0.000575	0.0039	CcSEcCtD
Indacaterol—Infestation NOS—Docetaxel—ovarian cancer	0.000572	0.00388	CcSEcCtD
Indacaterol—Infestation—Docetaxel—ovarian cancer	0.000572	0.00388	CcSEcCtD
Indacaterol—Dyspnoea—Vinorelbine—ovarian cancer	0.00057	0.00387	CcSEcCtD
Indacaterol—Cardiac disorder—Paclitaxel—ovarian cancer	0.000562	0.00381	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000552	0.00375	CcSEcCtD
Indacaterol—Hypersensitivity—Topotecan—ovarian cancer	0.000551	0.00374	CcSEcCtD
Indacaterol—Immune system disorder—Paclitaxel—ovarian cancer	0.000547	0.00371	CcSEcCtD
Indacaterol—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000546	0.0037	CcSEcCtD
Indacaterol—Hypersensitivity—Melphalan—ovarian cancer	0.00054	0.00366	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000533	0.00361	CcSEcCtD
Indacaterol—Pruritus—Topotecan—ovarian cancer	0.000529	0.00359	CcSEcCtD
Indacaterol—Malnutrition—Paclitaxel—ovarian cancer	0.000527	0.00358	CcSEcCtD
Indacaterol—Pruritus—Melphalan—ovarian cancer	0.000518	0.00351	CcSEcCtD
Indacaterol—Muscle spasms—Paclitaxel—ovarian cancer	0.000507	0.00344	CcSEcCtD
Indacaterol—Oedema peripheral—Docetaxel—ovarian cancer	0.000506	0.00343	CcSEcCtD
Indacaterol—Connective tissue disorder—Docetaxel—ovarian cancer	0.000505	0.00342	CcSEcCtD
Indacaterol—Nausea—Chlorambucil—ovarian cancer	0.000499	0.00338	CcSEcCtD
Indacaterol—Dizziness—Topotecan—ovarian cancer	0.000495	0.00335	CcSEcCtD
Indacaterol—Tremor—Paclitaxel—ovarian cancer	0.000494	0.00335	CcSEcCtD
Indacaterol—Anaemia—Paclitaxel—ovarian cancer	0.000487	0.00331	CcSEcCtD
Indacaterol—Cardiac disorder—Docetaxel—ovarian cancer	0.000477	0.00323	CcSEcCtD
Indacaterol—Vertigo—Paclitaxel—ovarian cancer	0.000474	0.00321	CcSEcCtD
Indacaterol—Rash—Topotecan—ovarian cancer	0.000472	0.0032	CcSEcCtD
Indacaterol—Hypersensitivity—Vinorelbine—ovarian cancer	0.000471	0.0032	CcSEcCtD
Indacaterol—Dermatitis—Topotecan—ovarian cancer	0.000471	0.0032	CcSEcCtD
Indacaterol—Headache—Topotecan—ovarian cancer	0.000469	0.00318	CcSEcCtD
Indacaterol—Palpitations—Paclitaxel—ovarian cancer	0.000466	0.00316	CcSEcCtD
Indacaterol—Immune system disorder—Docetaxel—ovarian cancer	0.000464	0.00315	CcSEcCtD
Indacaterol—Mediastinal disorder—Docetaxel—ovarian cancer	0.000463	0.00314	CcSEcCtD
Indacaterol—Rash—Melphalan—ovarian cancer	0.000462	0.00313	CcSEcCtD
Indacaterol—Dermatitis—Melphalan—ovarian cancer	0.000461	0.00313	CcSEcCtD
Indacaterol—Cough—Paclitaxel—ovarian cancer	0.00046	0.00312	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—ovarian cancer	0.000456	0.00309	CcSEcCtD
Indacaterol—Pruritus—Vinorelbine—ovarian cancer	0.000453	0.00307	CcSEcCtD
Indacaterol—Myalgia—Paclitaxel—ovarian cancer	0.000449	0.00304	CcSEcCtD
Indacaterol—Chest pain—Paclitaxel—ovarian cancer	0.000449	0.00304	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—ovarian cancer	0.000448	0.00304	CcSEcCtD
Indacaterol—Malnutrition—Docetaxel—ovarian cancer	0.000447	0.00303	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000446	0.00302	CcSEcCtD
Indacaterol—Nausea—Topotecan—ovarian cancer	0.000444	0.00301	CcSEcCtD
Indacaterol—Dry mouth—Paclitaxel—ovarian cancer	0.000439	0.00298	CcSEcCtD
Indacaterol—Nausea—Melphalan—ovarian cancer	0.000435	0.00295	CcSEcCtD
Indacaterol—Asthma—Epirubicin—ovarian cancer	0.000433	0.00293	CcSEcCtD
Indacaterol—Muscle spasms—Docetaxel—ovarian cancer	0.00043	0.00291	CcSEcCtD
Indacaterol—Infection—Paclitaxel—ovarian cancer	0.000428	0.0029	CcSEcCtD
Indacaterol—Dizziness—Vinorelbine—ovarian cancer	0.000423	0.00287	CcSEcCtD
Indacaterol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000422	0.00286	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—ovarian cancer	0.000422	0.00286	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—ovarian cancer	0.000421	0.00286	CcSEcCtD
Indacaterol—Tachycardia—Paclitaxel—ovarian cancer	0.00042	0.00285	CcSEcCtD
Indacaterol—Skin disorder—Paclitaxel—ovarian cancer	0.000418	0.00284	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000414	0.00281	CcSEcCtD
Indacaterol—Anaemia—Docetaxel—ovarian cancer	0.000413	0.0028	CcSEcCtD
Indacaterol—Rash—Vinorelbine—ovarian cancer	0.000403	0.00274	CcSEcCtD
Indacaterol—Dermatitis—Vinorelbine—ovarian cancer	0.000403	0.00273	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000402	0.00273	CcSEcCtD
Indacaterol—Headache—Vinorelbine—ovarian cancer	0.000401	0.00272	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—ovarian cancer	0.0004	0.00272	CcSEcCtD
Indacaterol—Palpitations—Docetaxel—ovarian cancer	0.000395	0.00268	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000392	0.00266	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—ovarian cancer	0.00039	0.00265	CcSEcCtD
Indacaterol—Cough—Docetaxel—ovarian cancer	0.00039	0.00265	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—ovarian cancer	0.00039	0.00264	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—ovarian cancer	0.000388	0.00263	CcSEcCtD
Indacaterol—Paraesthesia—Paclitaxel—ovarian cancer	0.000386	0.00262	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—ovarian cancer	0.000386	0.00262	CcSEcCtD
Indacaterol—Infestation—Epirubicin—ovarian cancer	0.000386	0.00262	CcSEcCtD
Indacaterol—Dyspnoea—Paclitaxel—ovarian cancer	0.000384	0.0026	CcSEcCtD
Indacaterol—Chest pain—Docetaxel—ovarian cancer	0.000381	0.00258	CcSEcCtD
Indacaterol—Myalgia—Docetaxel—ovarian cancer	0.000381	0.00258	CcSEcCtD
Indacaterol—Nausea—Vinorelbine—ovarian cancer	0.00038	0.00258	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000378	0.00256	CcSEcCtD
Indacaterol—Dry mouth—Docetaxel—ovarian cancer	0.000372	0.00252	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000372	0.00252	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000372	0.00252	CcSEcCtD
Indacaterol—Infection—Docetaxel—ovarian cancer	0.000362	0.00246	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—ovarian cancer	0.000362	0.00245	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000361	0.00245	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—ovarian cancer	0.000359	0.00244	CcSEcCtD
Indacaterol—Nervous system disorder—Docetaxel—ovarian cancer	0.000358	0.00243	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—ovarian cancer	0.000357	0.00242	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—ovarian cancer	0.000357	0.00242	CcSEcCtD
Indacaterol—Tachycardia—Docetaxel—ovarian cancer	0.000356	0.00241	CcSEcCtD
Indacaterol—Skin disorder—Docetaxel—ovarian cancer	0.000354	0.0024	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—ovarian cancer	0.000341	0.00231	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—ovarian cancer	0.00034	0.00231	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—ovarian cancer	0.000335	0.00227	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000332	0.00225	CcSEcCtD
Indacaterol—Paraesthesia—Docetaxel—ovarian cancer	0.000328	0.00222	CcSEcCtD
Indacaterol—Dyspnoea—Docetaxel—ovarian cancer	0.000325	0.00221	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—ovarian cancer	0.000321	0.00218	CcSEcCtD
Indacaterol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000317	0.00215	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—ovarian cancer	0.000316	0.00214	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000315	0.00214	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000315	0.00214	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—ovarian cancer	0.000313	0.00212	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000312	0.00212	CcSEcCtD
Indacaterol—Pruritus—Paclitaxel—ovarian cancer	0.000304	0.00207	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—ovarian cancer	0.000301	0.00204	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000297	0.00202	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—ovarian cancer	0.00029	0.00197	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—ovarian cancer	0.000289	0.00196	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000289	0.00196	CcSEcCtD
Indacaterol—Dizziness—Paclitaxel—ovarian cancer	0.000285	0.00193	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—ovarian cancer	0.000279	0.00189	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—ovarian cancer	0.000279	0.00189	CcSEcCtD
Indacaterol—Rash—Paclitaxel—ovarian cancer	0.000271	0.00184	CcSEcCtD
Indacaterol—Dermatitis—Paclitaxel—ovarian cancer	0.000271	0.00184	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—ovarian cancer	0.000271	0.00184	CcSEcCtD
Indacaterol—Headache—Paclitaxel—ovarian cancer	0.00027	0.00183	CcSEcCtD
Indacaterol—Hypersensitivity—Docetaxel—ovarian cancer	0.000269	0.00182	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—ovarian cancer	0.000268	0.00182	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—ovarian cancer	0.000266	0.00181	CcSEcCtD
Indacaterol—Cough—Epirubicin—ovarian cancer	0.000263	0.00178	CcSEcCtD
Indacaterol—Pruritus—Docetaxel—ovarian cancer	0.000258	0.00175	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—ovarian cancer	0.000258	0.00175	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—ovarian cancer	0.000257	0.00174	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—ovarian cancer	0.000257	0.00174	CcSEcCtD
Indacaterol—Nausea—Paclitaxel—ovarian cancer	0.000256	0.00173	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000255	0.00173	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—ovarian cancer	0.000251	0.0017	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—ovarian cancer	0.000251	0.0017	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—ovarian cancer	0.000247	0.00167	CcSEcCtD
Indacaterol—Infection—Epirubicin—ovarian cancer	0.000244	0.00166	CcSEcCtD
Indacaterol—Cough—Doxorubicin—ovarian cancer	0.000243	0.00165	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—ovarian cancer	0.000241	0.00164	CcSEcCtD
Indacaterol—Dizziness—Docetaxel—ovarian cancer	0.000241	0.00164	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—ovarian cancer	0.00024	0.00163	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—ovarian cancer	0.000239	0.00162	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—ovarian cancer	0.000237	0.00161	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—ovarian cancer	0.000237	0.00161	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000236	0.0016	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—ovarian cancer	0.000232	0.00158	CcSEcCtD
Indacaterol—Rash—Docetaxel—ovarian cancer	0.00023	0.00156	CcSEcCtD
Indacaterol—Dermatitis—Docetaxel—ovarian cancer	0.00023	0.00156	CcSEcCtD
Indacaterol—Headache—Docetaxel—ovarian cancer	0.000229	0.00155	CcSEcCtD
Indacaterol—Infection—Doxorubicin—ovarian cancer	0.000226	0.00153	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000224	0.00152	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000223	0.00151	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—ovarian cancer	0.000222	0.00151	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—ovarian cancer	0.000221	0.0015	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—ovarian cancer	0.000221	0.0015	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—ovarian cancer	0.000219	0.00149	CcSEcCtD
Indacaterol—Nausea—Docetaxel—ovarian cancer	0.000217	0.00147	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000212	0.00144	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000207	0.00141	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—ovarian cancer	0.000204	0.00139	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—ovarian cancer	0.000203	0.00138	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000197	0.00133	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—ovarian cancer	0.000181	0.00123	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—ovarian cancer	0.000174	0.00118	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000168	0.00114	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—ovarian cancer	0.000163	0.0011	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—ovarian cancer	0.000161	0.00109	CcSEcCtD
Indacaterol—Rash—Epirubicin—ovarian cancer	0.000155	0.00105	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—ovarian cancer	0.000155	0.00105	CcSEcCtD
Indacaterol—Headache—Epirubicin—ovarian cancer	0.000154	0.00105	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—ovarian cancer	0.000151	0.00102	CcSEcCtD
Indacaterol—Nausea—Epirubicin—ovarian cancer	0.000146	0.000991	CcSEcCtD
Indacaterol—Rash—Doxorubicin—ovarian cancer	0.000144	0.000974	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—ovarian cancer	0.000143	0.000973	CcSEcCtD
Indacaterol—Headache—Doxorubicin—ovarian cancer	0.000143	0.000967	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—ovarian cancer	0.000135	0.000917	CcSEcCtD
